Liver hemangioma

What is a liver hemangioma?

A liver hemangioma is a completely non-cancerous (benign) lump in the liver made of an abnormal cluster of blood vessels. It is not skin or liver cancer, it does not spread to other organs, and it will never turn into cancer.

Liver hemangiomas are classified by size:

• Typical (under 5 cm): the most common type. They cause zero symptoms, require no treatment, and are perfectly safe to leave alone.

• Giant (5 cm or larger): rare. Because of their size, they can occasionally cause a dull ache in your stomach, clot internally, or carry a very small risk of bleeding.

An Elfcare MRI can instantly recognize a hemangioma by its distinct pattern on the scan, showing how blood fills the cluster from the outside edge inward. This unique visual footprint allows doctors to give you a definitive diagnosis on the spot without needing an invasive and risky liver biopsy.

Symptoms of liver hemangiomas

The vast majority of liver hemangiomas cause no symptoms and are discovered entirely incidentally on abdominal imaging. When symptoms occur they are almost exclusively associated with large or giant hemangiomas:

• A dull aching discomfort or heaviness in the upper right abdomen from mass effect on surrounding structures

• Early satiety or nausea from compression of adjacent stomach by very large lesions

• A palpable abdominal mass in very large lesions

• Acute severe abdominal pain from spontaneous haemorrhage, an extremely rare complication in giant lesions

• In Kasabach-Merritt syndrome, which is exceptionally rare, bleeding and bruising from platelet consumption within the lesion

For the overwhelming majority of people with a liver hemangioma, the only relevant consequence of the finding is the reassurance that the liver lesion has a benign explanation.

What causes liver hemangiomas?

The exact cause of liver hemangioma development is not fully understood. Contributing factors include:

• Congenital vascular malformation liver hemangiomas are thought to arise from a congenital abnormality in the development of hepatic vascular tissue, present from birth or early life even if not identified until adulthood.

• Female sex and hormonal factors liver hemangiomas are approximately twice as common in women as in men, and oestrogen is thought to promote their growth. They may enlarge during pregnancy and with oestrogen-containing hormone therapy.

• Age hemangiomas become more commonly identified with age, likely reflecting both the increased use of abdominal imaging in older adults and possible slow growth over time.

• Genetic factors occasional familial clustering suggests a genetic predisposition in some cases, though most arise without an identified hereditary cause.

How is a liver hemangioma detected?

Liver hemangiomas are detected through abdominal imaging. Blood tests play a very limited role in the assessment of the hemangioma itself but are relevant to overall liver health assessment.

Abdominal MRI Elfcare’s full body MRI maps your liver to immediately spot and identify hemangiomas. Thanks to its high-resolution detail, the scan uses the lesion's distinct bright signal pattern to reliably tell a harmless blood vessel cluster apart from more aggressive liver lesions, without the need for a liver biopsy. The scan also tracks the growth's exact size and counts how many are present, giving you a clear baseline to ensure your liver remains perfectly healthy.

Blood tests cannot detect liver hemangiomas directly but assess overall liver health and identify any conditions that may coexist with or be confused with a hemangioma. Relevant markers in Elfcare's panel include:

• ALT, AST, GGT, ALP, and bilirubin a comprehensive liver function profile confirms the absence of significant liver parenchymal disease, relevant context when a liver lesion is identified

• Albumin reflects liver synthetic function, confirming overall hepatic health alongside structural findings

• CRP systemic inflammation relevant to distinguishing an inflammatory lesion from a vascular one in uncertain cases

• HbA1c and glucose metabolic health assessment relevant to overall liver health context, as fatty liver disease and diabetes affect the liver parenchyma in which a hemangioma sits

• Haemoglobin and platelet count in giant hemangiomas, to screen for evidence of Kasabach-Merritt syndrome with platelet consumption, though this complication is exceptionally rare

Why early detection matters

For the vast majority of liver hemangiomas, early detection is primarily important for the reassurance it provides rather than for any clinical intervention. A liver lesion discovered incidentally on imaging, without a confident diagnosis, generates significant anxiety. An MRI that characterises the lesion as a classic hemangioma immediately and definitively ends that anxiety, replacing uncertainty with a clear and reassuring explanation. For women taking estrogen-containing hormone therapy or planning pregnancy, knowing about a hemangioma allows for appropriate monitoring, as oestrogen exposure can promote growth. For the rare large or giant hemangioma, early identification allows for monitoring before any complication develops.

How Elfcare can help

Elfcare's full body MRI images the liver directly as part of the standard abdominal sequence, identifying liver hemangiomas and providing the characteristic MRI appearance that confirms the diagnosis with high confidence in the vast majority of cases. For a finding that causes significant anxiety when discovered, a confident imaging diagnosis of a benign hemangioma provides immediate and definitive reassurance.

Our blood panel covers a comprehensive liver function profile, confirming the absence of significant liver disease and providing the systemic context alongside the structural MRI findings.

If our MRI identifies a liver lesion with features consistent with a hemangioma, we take care of further diagnostics or refer you to the appropriate specialist where any uncertainty exists about the diagnosis.